Viagra challengers will reach the domestic market

Published: 2003-02-11 07:00:00

Updated: 2003-02-11 07:00:00

Business sources say that the domestic anti-impotence drugs market, which has been predominated by Pfizer's Viagra, will emerge as an arena of fierce competition among four pharmaceutical firms, Eli Liily' Cialis (tadalafil) and Levitra (vardenafil) will be launched during the latter half of this...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK